Patients with advanced pancreatic and biliary cancer appear vulnerable to SARS-CoV-2 Omicron variant: An observational study during the COVID-19 outbreak in Shanghai

Patients with advanced pancreatic and biliary cancer appear vulnerable to SARS-CoV-2 Omicron variant: An observational study during the COVID-19 outbreak in Shanghai

BackgroundThe COVID-19 pandemic has spread rapidly across the globe. Cancer patients have a higher risk of severe infections and associated mortality than the general population. However, the lethal effect of Omicron-variant affection on advanced pancreatic and biliary cancer patients is still not c...

Full description

Bibliographic Details
Main Authors: Tao Han, Lujun Chen, Jia Gu, Shen Wu, Maiweilan Maihemuti, Jue Yang, Hao Wang, Jun Wu, Yue Zhang, Yun Cong, Jiening Wang, Tingsong Chen
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-03-01
Series:Frontiers in Oncology
Subjects:
pancreatic and biliary cancer
COVID-19
SARS-CoV-2 omicron
immunosuppression
vulnerable population
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1115293/full

Similar Items

Similar Items